Riskpilot← Back to searchSign inGet full accessBTS Medical AB
ABActiveOrg 5592742968Iversonsgatan 2Organisation of conventions and trade shows · NACE 8230Est. 20200 employees
Revenue 2025
SEK 13,3M
+19% vs 2024
EBITDA margin
55.1%
+411% vs 2024
Equity ratio
76.9%
Financial strength
Net profit 2025
SEK 5,8M
+416% vs 2024
| Revenue | SEK 13,3M | +19% |
| EBITDA | SEK 7,3M | +411% |
| Net profit | SEK 5,8M | +416% |
| Total assets | SEK 20,6M | +51% |
| Equity | SEK 15,8M | +58% |
| Employees | 0 | — |
Legal name
BTS Medical AB
Org number
5592742968
Legal form
Aktiebolag
NACE code
8230 · Organisation of conventions and trade shows
Founded
30 september 2020
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk utbildning, kongress verksamhet och därmed förenlig verksamhet.
Address
Iversonsgatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 305 | 8 984 | 9 641 | 11 179 | 13 296 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 648 | 4 006 | 4 534 | 1 434 | 7 323 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 2 648 | 4 006 | 4 534 | 1 434 | 7 323 |
| Net financials | −1 | −1 | −42 | −1 | 32 |
| Profit before tax | 2 647 | 4 005 | 4 494 | 1 433 | 7 355 |
| Tax | −568 | −831 | −936 | −302 | −1 526 |
| Net profit | 2 079 | 3 174 | 3 558 | 1 130 | 5 828 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 042 | 10 969 | 14 558 | 13 647 | 20 580 |
| Equity | 2 129 | 5 303 | 8 861 | 9 991 | 15 820 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 3 912 | 5 666 | 5 697 | 3 656 | 4 760 |
| Total debt | 3 912 | 5 666 | 5 697 | 3 656 | 4 760 |
EBITDA margin
55.1%
This company
15.8%
Market median
+249% vs market
20212025
Equity ratio
76.9%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
36.8%
This company
18.4%
Market median
+100% vs market
20212025
Net profit margin
43.8%
This company
8.1%
Market median
+441% vs market
20212025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Audit | Audit | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr Hedén AB
BTS Medical AB Board members of BTS Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Johan Rendert | Audit | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Ebba Maria Helena Stark Hedén | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Per Göran Hedén | Board of Directors | 0 companies |